-
Fujifilm to acquire 2 biotech units for $800M
biospectrumasia
April 02, 2018
Fujifilm plans to acquire all outstanding shares of Irvine Scientific (ISUS) and IS Japan (ISJ).
-
CRH Medical Corporation Announces the Purchase of Shreveport Sedation Associates
biospace
March 20, 2018
CRH Medical Corporation announces that it has completed an accretive transaction whereby CRH has acquired a gastroenterology ("GI") anesthesia practice (100%) in Shreveport, Louisiana ("Shreveport").
-
Agilent Technologies to acquire Advanced Analytical Tech
biospectrumasia
March 08, 2018
This acquisition will enhance Agilent’s existing expertise and technology, while giving customers a more comprehensive set of solutions.
-
Celgene Scoops Up San Diego Biotech in $7B Deal
biospace
January 09, 2018
Celgene began the week of the J.P. Morgan Healthcare Conference with a $7 billion announcement. The company said it will acquire San Diego-based Impact Biomedicines and its JAK inhibitor progra
-
Nuvo Pharmaceuticals acquires global product rights to Resultz®
pharmaasia
January 05, 2018
Nuvo Pharmaceuticals Inc.has announced its acquisition of the global, ex-U.S.rights to Resultz® from Piedmont Pharmaceuticals LLC.
-
Thermo Fisher acquires Phenom World
biospectrumasia
January 02, 2018
The addition of Phenom World's leading desktop SEM platform strengthens Thermo Fisher's leadership in electron microscopy.
-
Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal
biospace
December 28, 2017
Mallinckrodt, based in Staines-Upon-Thames, UK, is acquiring Rockville, Maryland-based Sucampo Pharmaceuticals for $1.2 billion.
-
Roche boosts oncology portfolio with $1.7bn acquisition
pharmafile
December 25, 2017
Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for $1.7 billion.
-
Centinel Spine Completes Acquisition of prodisc Assets
prnasia
December 25, 2017
Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy Synthes Products, Inc.
-
JSR Life Sciences Snaps Up CRO in $400M Deal
biospace
December 21, 2017
The parent company of JSR Life Sciences snapped up contract research organization Crown Bioscience International for $400 million, the company announced this morning.